about the author

ENDPOINTS

editor@endpointsnews.com

author articles

Pfiz­er Foun­da­tion of­fers $2M in grants to NGOs tack­ling an­timi­cro­bial re­sis­tance; Bio­gen, In­vi­tae join forces to ...

6 years ago
News Briefing

Glen­mark launch­es Re­mogliflozin com­bo in In­dia; Gene­Cen­tric Ther­a­peu­tics buys Se­lect Im­munoGenomics

6 years ago
News Briefing

Bain's Or­ly Mis­han joins Pfiz­er's neu­ro spin­out Cerev­el; On­colyt­ic virus biotech taps Sil­la­Jen ex­ec He­le­na Chaye as ...

6 years ago
Peer Review

Ebo­la tri­al stopped ear­ly as Re­gen­eron, Ridge­back ther­a­pies cut death risk; Mer­ck inks deal to test Keytru­da with ...

6 years ago
News Briefing

Boris John­son pledges £250M to spur AI adop­tion in NHS; SQZ scoops CFO Teri Lox­am from Mer­ck

6 years ago
News Briefing

Peer Re­view: Ru­bius re­cruits BD chief; Epizyme hires No­var­tis vet as CFO

6 years ago
Peer Review

Seer adds ex-FDA chief Mark Mc­Clel­lan to the board; Her­cules Cap­i­tal makes it of­fi­cial for new CEO Scott Bluestein

6 years ago
Peer Review

Gold­man Sach­s' Ankang Li heads to biotech Terns as new CFO; SV re­cruits new part­ner for De­men­tia Dis­cov­ery Fund

6 years ago
Peer Review

Up­dat­ed: Lon­za sets sights on ex­pan­sion, buy­ing No­var­tis fa­cil­i­ty; IQVIA leads $14 mil­lion Se­ries B fund­ing round

6 years ago
News Briefing

Evan Loh climbs the lad­der to be­come CEO at Paratek Phar­ma­ceu­ti­cals; Co­di­ak's Doug Williams takes chair­man's role at ...

6 years ago
Peer Review

On­coSec signs on Dana-Far­ber as CAR-T part­ner; Do­va racks up an­oth­er Doptelet ap­proval

6 years ago
News Briefing

Alex­ion wins pri­or­i­ty re­view for Ul­tomiris' aHUS in­di­ca­tion; FDA ex­pands ap­proval of Ver­tex's Symdeko

6 years ago
News Briefing

Maze in­ter­im chief Charles Hom­cy pass­es ba­ton to Ja­son Colo­ma; William Col­lier tapped as CEO of Ar­bu­tus

6 years ago
Peer Review

Arc­turus ex­pands col­lab­o­ra­tion, adding $30M cash; Ku­ra shoots for $100M raise

6 years ago
News Briefing

Uni­ty's ear­ly longevi­ty da­ta look 'en­cour­ag­ing'; Adap­tive Biotech­nolo­gies looks to raise $200M in IPO

6 years ago
News Briefing

A uni­corn stalks Wall Street in search of IPO cash; CASI Phar­ma in-li­cens­es CD19 ther­a­py from Chi­na’s Ju­ven­tas

6 years ago
News Briefing

News­mak­ers at #EHA19: Re­gen­eron, Ar­Qule track progress on re­sponse rates

6 years ago
R&D

Ab­b­Vie touts new da­ta for Hu­mi­ra suc­ces­sor; Gilead inks dis­cov­ery deal

6 years ago
News Briefing

Deer­field strikes up new deal with Co­lum­bia Uni­ver­si­ty; Ovid CEO Je­re­my Levin joins BIO as new board chair

6 years ago
News Briefing

Cel­gene/Ac­celeron win speedy FDA re­view for lus­pa­ter­cept in be­ta tha­lassemia; Ko­re­an in­vestor out to shake up ...

6 years ago
News Briefing

No­var­tis backs $30M round for can­cer biotech; Bay­er drug makes a ‘break­through’ at FDA

6 years ago
News Briefing

5 cash-hun­gry biotechs crowd in­to Nas­daq in search of a $600M-plus wind­fall

6 years ago
Financing

Akre­via scoops ex-Ar­sa­nis chief René Rus­so as CEO; Scott Got­tlieb jumps back in­to in­dus­try; Seat­tle Ge­net­ics raids ...

6 years ago
Peer Review

Iso­Plex­is bags $25M to stoke T cell ther­a­py buzz; Col­lab­o­ra­tion be­tween X4 and LLS; New CMO at Pre­ci­sion Bio­sciences

6 years ago
News Briefing
First page Previous page 16171819202122 Next page Last page
A service from the Financial Times